These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3644127)

  • 1. [Prevalence of anti-HTLV-III antibodies in volunteer blood donors in Guipuzcoa].
    Cortés A; Francisco C; Larrañaga MJ; Cárdenas JM
    Med Clin (Barc); 1987 Jan; 88(1):38-9. PubMed ID: 3644127
    [No Abstract]   [Full Text] [Related]  

  • 2. Significance of anti-HTLV-III testing of volunteer blood donors.
    Grindon AJ
    Beitr Infusionther Klin Ernahr; 1987; 18():1-5. PubMed ID: 3326580
    [No Abstract]   [Full Text] [Related]  

  • 3. [Screening of antiviral antibodies of human immunodeficiency in blood donors].
    Gelabert Blanes A
    Med Clin (Barc); 1987 May; 89(1):14-6. PubMed ID: 3475520
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prevalence of anti-HTLV-III antibodies in blood donors and risk populations in Zaragoza].
    Callén L; Gutiérrez M; Lasierra P; Larrad L
    Med Clin (Barc); 1986 Jun; 87(2):82. PubMed ID: 3461230
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevalence of transfusion-associated viral infections and syphilis among blood donors in Muhimbili Medical Centre, Dar es Salaam, Tanzania.
    Matee MI; Lyamuya EF; Mbena EC; Magessa PM; Sufi J; Marwa GJ; Mwasulama OJ; Mbwana J
    East Afr Med J; 1999 Mar; 76(3):167-71. PubMed ID: 10442119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Donors with positive antibodies against HIV virus in Red Cross blood banks].
    Franco E; Picazo J; Mazón C; Antich JL; Lafulla C; Ribó E; Contreras E
    Sangre (Barc); 1986; 31(6):775-6. PubMed ID: 3470958
    [No Abstract]   [Full Text] [Related]  

  • 7. [Survey of antiviral antibodies against human immunodeficiency virus in a population of 11,174 blood donors].
    Muñiz Díaz E; Madoz P; Lluch A
    Med Clin (Barc); 1987 Nov; 89(16):709-10. PubMed ID: 3480407
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prevalence of antibodies against HTLV-III in the at risk population in Madrid. Clinical study and incidence of virologic markers].
    González Lahoz JM; Gutiérrez Angulo MT; Polo Rodríguez R; Subirats Núñez M; Moreno Celda V; Baquero Mochales M
    Rev Clin Esp; 1987 May; 180(8):416-9. PubMed ID: 3649830
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-HIV screening in Canadian blood donors.
    CMAJ; 1986 Oct; 135(8):901. PubMed ID: 3463387
    [No Abstract]   [Full Text] [Related]  

  • 10. Anti-HTLV III testing of blood donors and recipients, Hawaii experience.
    Frohlich J
    Hawaii Med J; 1986 Nov; 45(11):391-2. PubMed ID: 3468095
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevalence of HTLV-III antibody in American blood donors.
    Schorr JB; Berkowitz A; Cumming PD; Katz AJ; Sandler SG
    N Engl J Med; 1985 Aug; 313(6):384-5. PubMed ID: 3859750
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prevalence of viral antibodies and syphilis serology in blood donors from a hospital].
    Pita-Ramírez L; Torres-Ortiz GE
    Rev Invest Clin; 1997; 49(6):475-80. PubMed ID: 9528308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological and molecular screening for viruses in blood donors from Ntcheu, Malawi: high prevalence of HIV-1 subtype C and of markers of hepatitis B and C viruses.
    Candotti D; Mundy C; Kadewele G; Nkhoma W; Bates I; Allain JP
    J Med Virol; 2001 Sep; 65(1):1-5. PubMed ID: 11505436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening blood donors for HTLV-III antibody.
    Mann DA
    JAMA; 1986 Nov; 256(17):2344-5. PubMed ID: 3534328
    [No Abstract]   [Full Text] [Related]  

  • 15. HIV antibody in blood donors in Argentina.
    Muchinik G; Picchio G; Livellara B; Martín E; Gatti H; Morisoli L; González L; Taborda M; Fay O
    Boll Ist Sieroter Milan; 1987; 66(6):491-2. PubMed ID: 3453153
    [No Abstract]   [Full Text] [Related]  

  • 16. [Serological survey on the prevalence of anti-HTLV-III antibodies in a psychiatric hospital].
    Antila CC; Blotta MH; Gomes MC
    Rev Paul Med; 1986; 104(6):328. PubMed ID: 3650926
    [No Abstract]   [Full Text] [Related]  

  • 17. Seroprevalence of six different viruses among pregnant women and blood donors in rural and urban Burkina Faso: A comparative analysis.
    Collenberg E; Ouedraogo T; Ganamé J; Fickenscher H; Kynast-Wolf G; Becher H; Kouyaté B; Kräusslich HG; Sangaré L; Tebit DM
    J Med Virol; 2006 May; 78(5):683-92. PubMed ID: 16555290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of routine HTLV-III antibody testing on public health.
    Natl Inst Health Consens Dev Conf Consens Statement; 1986; 6(5):1-9. PubMed ID: 3537748
    [No Abstract]   [Full Text] [Related]  

  • 19. Serologic and molecular typing of human T-lymphotropic virus among blood donors in Maputo City, Mozambique.
    Gudo ES; Abreu CM; Mussá T; Augusto Ado R; Otsuki K; Chambo E; Amade N; Tanuri A; Ferreira OC; Jani IV;
    Transfusion; 2009 Jun; 49(6):1146-50. PubMed ID: 19222818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anti-HTLV III antibodies in the personnel of a hospital in the Campania region].
    Ferro V; Sapia P; Perna C; Salvi MP; Piscopo V
    Quad Sclavo Diagn; 1986 Mar; 22(1):104-9. PubMed ID: 3641325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.